On the Corner of Models and Cure: Gene Editing in Cystic Fibrosis
Cystic fibrosis (CF) is a severe genetic disease for which curative treatment is still lacking. Next generation biotechnologies and more efficient cell-based and in vivo disease models are accelerating the development of novel therapies for CF. Gene editing tools, like CRISPR-based systems, can be u...
Main Authors: | Marjolein Ensinck, Angélique Mottais, Claire Detry, Teresinha Leal, Marianne S. Carlon |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.662110/full |
Similar Items
-
Cystic fibrosis mutation spectrum in north macedonia: A step toward personalized therapy
by: Terzic M, et al.
Published: (2019-08-01) -
Animal Models in the Pathophysiology of Cystic Fibrosis
by: Anna Semaniakou, et al.
Published: (2019-01-01) -
Two years of newborn screening for cystic fibrosis in North Macedonia: First experience
by: Fustik S, et al.
Published: (2021-07-01) -
Liver Failure in a Chinese Cystic Fibrosis Child With Homozygous R553X Mutation
by: Haiyan Li, et al.
Published: (2019-02-01) -
'CFTR-opathies': disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations
by: Knowles Michael R, et al.
Published: (2001-08-01)